Navigation Links
Insight offers new angle of attack on variety of brain tumors
Date:12/15/2010

A newly published insight into the biology of many kinds of less-aggressive but still lethal brain tumors, or gliomas, opens up a wide array of possibilities for new therapies, according to scientists at Brown University and the University of California, San Francisco (UCSF). In paper published online Dec. 15 in the Journal of the National Cancer Institute, they describe how a genetic mutation leads to an abnormal metabolic process in the tumors that could be targeted by drug makers.

"What this tells you is that there are some forms of tumors with a fundamentally altered process," said Karl Kelsey, a professor of pathology and laboratory medicine and community health in the Warren Alpert Medical School of Brown and one of the paper's senior authors. "This is a really new way to look at potentially modifiable factors in brain tumors."

Scientists have known for a couple of years that a mutation in a gene called IDH is associated with glioma. They've also observed that people with gliomas carrying the mutation survive longer than those afflicted with tumors lacking the mutation. What the Brown and UCSF team show in the new paper is that the mutation is associated with a consistent pattern of an alteration known as "methylation" of the DNA which is associated with changes in gene expression. The pattern of methylation in tumors with the IDH mutation often occurred in metabolic genes, regardless of the tumor's specific type.

Margaret Wrensch, a professor of neurological surgery, epidemiology and biostatistics at UCSF's Helen Diller Family Comprehensive Cancer Center, said what the team found surprising is that DNA from almost all tumors with IDH mutations had the same distinctive methylation pattern. The degree of methylation throughout the genome was unusually high, and the same specific DNA was methylated.

"This one mutation is common to a whole subset of brain tumors," she said. "It's quite unique. It seems to dominate other mutations in the tumor and the epigenetic changes are very uniform."

The researchers hope now that if a drug could inhibit this methylation process in any number of these affected genes, not necessarily just IDH, that might correct the errant metabolism of the tumors and control their growth.

"We know now that there are all these genes related to metabolism that have altered methylation," said Brock Christensen, a Brown postdoctoral scholar in pathology and laboratory medicine and a lead author of the paper, which also involved researchers from the University of Minnesota and Dartmouth Medical School. "In this suite of genes there might be a much easier target to try to design a therapy for."

The heart of the study was a tumor-by-tumor analysis of the methlylation, led by Christensen and Brown graduate student Ashley Smith, in scores of samples from the Brain Tumor Research Center at UCSF. Their analysis revealed an unusually iron clad correlation between the IDH mutation and methylation in metabolic genes in gliomas of many different names and classifications.

"The strength of the correlation was absolutely stunning," Christensen said. "It's not the kind of thing you see very often in cancer epidemiology, to have almost all of these mutant tumors having the same methylation profile."

The IDH gene has a role in glucose sensing, so the association of the mutation with altered metabolism genes (occurring through enhanced DNA methylation) is reasonable, Christensen said. The researchers are now looking into the role that mutation in IDH plays in perhaps altering other metabolism genes in the cells.

The research leaves many questions about brain tumors unanswered. Among them is what causes the IDH mutation, what causes the mutation to affect other genes in the cell, and most importantly, what is the best way take therapeutic advantage of these new observations.

But Kelsey said the fight against brain cancer has long had a dearth of hope, so he's encouraged to see some emerge.

"Gliomas are such a deadly disease, and so little is known about them, that people are pretty excited about this because it is a whole new way in," he said. "We have a new clue about what to study."


'/>"/>

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University
Source:Eurekalert

Related medicine news :

1. Hallmark Insights Completes SAS 70 Type II Audit
2. Employers Voice Opinions on Health Care Plans, Gain Insights on Health Care Reform
3. Happy Feet Clinic Now Open in Buffalo Grove, IL; Starting A Business in Impossible Times: Valuable Insights and Experiences
4. Insightra Medical Inc Gains CE Mark on the Freedom(TM) Inguinal Hernia Product Range
5. Rwandan genocide survivors provide new insights into resilience and PTSD
6. TeraMedica Inks Reseller Agreement With Medical Insight Enterprise Image Viewer Company
7. Carefx Delivers Expert Insights on Health Data Sharing, Collaboration, Quality and Meaningful Use
8. ADD Insights, LLC and The New England ADHD Treatment Center Announce a Joint Seminar Series: Mastering One's ADHD
9. U discovery gives insight into brain replay process
10. Carnegie Mellon research provides insight into brains decision-making process
11. Media Alert: Model N and International Medical Device Leader to Share Insights on Maximizing Sales Performance with Revenue Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... ... As part of its ongoing series of aquatic therapy related webinars, HydroWorx ... dynamic expert and thoughtful presentation to give attendees a better sense of how to ... free to attend, but registration is required. , Rehabilitation of Offensive Lineman ...
(Date:2/10/2016)... Glendale, CA (PRWEB) , ... February 10, 2016 , ... ... can be harder to find. Unfortunately, this can leave patients with dental emergencies at ... Glendale , is now offering emergency dental care. , Common dental emergencies include:, ...
(Date:2/10/2016)... ... February 10, 2016 , ... Intalere’s 2016 ... more than 200 of the country’s top healthcare executives to share insights on ... benefit of the Forum is the provider-centric perspective, experience, expertise and strategy shared ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: ... winner and inspirational speaker Jan Fox will serve as keynote speaker at the ... provide participants with tools to more effectively communicate with their own organizational staff ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has joined ... readily available to physicians. The integration will enable Allscripts users to post open ... Everseat’s free mobile app. , The partnership gives Everseat substantial added power to ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , February 10, 2016 ... new market research report "Pharmaceutical Packaging Equipment Market by ... Labeling & Serialization), by Product Type (Tablet, Powder, Cream, ... published by MarketsandMarkets, studies the global market during the forecast ... to grow at a CAGR of 6.9% during the ...
(Date:2/10/2016)... , Feb. 9, 2016 On ... Administration (FDA) met with its Arthritis Advisory ... biosimilar of Johnson & Johnson,s Remicade and ... approved in the U.S. The Biologics Prescribers ... groups - Alliance for Patient Access, American ...
(Date:2/10/2016)... , February 10, 2016 ... Medicine, Targeted Therapeutics and Companion Diagnostic Market to ... Participants, and Environment" research report indicates that the ... $149 billion by 2020 growing at a CAGR ... companion diagnostics and targeted therapeutics and is dominated ...
Breaking Medicine Technology: